Erlotinib and pleural effusion 
Erlotinib and pleural effusion Patient Reports February 11, 2012
Erlotinib Side Effects Report #5224439-X
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 12, 2007. Male patient, 88 years of age, was diagnosed with prostate cancer
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood creatine increased, blood glucose increased, cardiac failure congestive, haemoglobin decreased, lung infiltration, nausea , pleural effusion, pulmonary oedema. Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with SYNTHROID, HUMULIN, FUROSEMIDE, COREG, LISINOPRIL, FERROUS SULPHATE, LEUPROLIDE ACETATE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5688186-2
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Mar 21, 2008. Female patient, 78 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood pressure diastolic decreased, central line infection, pericardial effusion, pleural effusion. Erlotinib dosage: (100 MG, QD) , ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, OMPRAZOLE, TEICOPLANIN, TIMETNTIN, VANCOMYCIN, LIDOCAINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5828462-3
Erlotinib side effect was reported by a Physician from GERMANY on July 15, 2008. Female patient, 74 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pericardial effusion, pleural effusion. Erlotinib dosage: 150 MG QD ORAL; 100 MG QD ORAL. During the same period patient was treated with GEMCITABINE, CORTISONE, MORPHINE, DIPYRONE, ENOXAPARIN. Patient recovered.
Erlotinib Side Effects Report #5136498-3
Erlotinib side effect was reported by a Physician from GERMANY on Oct 16, 2006. Female patient, 72 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, epistaxis, iatrogenic injury, lung injury, pleural effusion, pneumothorax. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with GEMCITABINE, ASPIRIN, NEXIUM, SIMVAHEXAL, XANEF, UNAT, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5196227-4
Erlotinib side effect was reported by a Physician from GERMANY on Dec 07, 2006. Female patient, 72 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, dyspnoea, epistaxis, pancreatic carcinoma metastatic, pleural effusion, pneumothorax. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with ASPIRIN, NEXIUM, SIMVAHEXAL, GEMCITABINE, XANEF, UNAT, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5230798-4
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Jan 17, 2007. Male patient, 59 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: depressed mood, fatigue, left ventricular failure, pleural effusion, vomiting. Erlotinib dosage: 100 MG QD, ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, OMEPRAZOLE, LOPERAMIDE, METOCLOPRAMIDE, FUROSEMIDE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5748790-X
Erlotinib side effect was reported by a Physician from JAPAN on May 06, 2008. Male patient, 70 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ascites, bone marrow failure, hypoalbuminaemia, oedema peripheral, pleural effusion, weight increased. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with GEMCITABINE, LEVOFLOXACIN, DEXAMETHASONE PHOSPHATE, GRANISETRON HYDROCHLORIDE, RABEPRAZOLE, PANCREATIC ENZYME, CAMOSTAT MESILATE, URSODIOL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6069106-8
Erlotinib side effect was reported by a Physician from GERMANY on Jan 20, 2009. Male patient, 52 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac failure, pleural effusion. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5324240-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 23, 2007. Female patient was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: metastases to lung, pleural effusion, pulmonary embolism
. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized and became disabled. Patient died on 04/04/2007.Erlotinib Side Effects Report #5001606-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 11, 2006. Male patient, weighting 190.6 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pleural effusion. Erlotinib dosage: 150MG Q DAY PO. During the same period patient was treated with BEVACIZUMAB, PROTONIX, REGLAN, PANCREASE MT, CLEOCIN T, ACETAMINOPHEN, SALT, TESSALON. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #4928557-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 08, 2006. Female patient, 65 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal distension, diarrhoea, dyspnoea, pleural effusion, pneumonia
, pulmonary embolism . Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5572355-6
Erlotinib side effect was reported by a Physician from ISRAEL on Dec 04, 2007. Male patient, 83 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, dyspnoea, pleural effusion, protein total decreased. Erlotinib dosage: (50 MG, QD), ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5984666-0
Erlotinib side effect was reported by a Physician from ISRAEL on Nov 18, 2008. Male patient, 82 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood bilirubin increased, blood lactate dehydrogenase increased, pleural effusion, pneumonitis, protein total decreased, white blood cell count decreased. Erlotinib dosage: 50 MG, QD, ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5765444-4
Erlotinib side effect was reported by a Physician from GERMANY on May 22, 2008. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac failure, cardiomegaly, dyspnoea exertional, neoplasm progression, pleural effusion, pulmonary congestion. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with NOVALGIN, ENOXAPARIN, NEXIUM, LYRICA OXYCODONE. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5262366-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 09, 2007. Male patient, weighting 169.0 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, disease progression, obstructive airways disorder, pleural effusion, pneumonia
. Erlotinib dosage: 175MG DAILY PO. During the same period patient was treated with NORVASC, NEXIUM, NOVOLOG, LANTUS, PRANDIN, VYTORIN, AMBIEN, OXYCODONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6132617-0
Erlotinib side effect was reported by a Physician from JAPAN on Mar 10, 2009. Male patient, 80 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood glucose decreased, gastric ulcer, haematemesis, interstitial lung disease, loss of consciousness, metastases to bone, metastases to lung, pleural effusion. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BASEN, AMARYL, PURSENNID, MAGMITT, OXYCONTIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5927963-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 22, 2008. Female patient, 73 years of age, weighting 123.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion. Erlotinib dosage: 150MG ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5956176-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 04, 2008. Female patient, 73 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5337724-8
Erlotinib side effect was reported by a Physician from UNITED STATES on May 09, 2007. Female patient, 72 years of age, weighting 266.8 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: hydropneumothorax, pleural effusion. Erlotinib dosage: 100 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5648138-5
Erlotinib side effect was reported by a Physician from JAPAN on Feb 14, 2008. Female patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaphylactic shock, diarrhoea, loss of consciousness, pleural effusion. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with PICIBANIL, UNASYN, BISOPROLOL FUMARATE, HALCION, ENTERONON, SUNRYTHM. Patient recovered.
Erlotinib Side Effects Report #5946023-2
Erlotinib side effect was reported by a Physician from ISRAEL on Oct 22, 2008. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cough, dyspnoea, nausea
, pleural effusion, respiratory failure, sepsis . Erlotinib dosage: 150 MG (150 MG, QD), ORAL. During the same period patient was treated with NORMITEN, GASTRO, ASPIRIN. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #6125147-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 02, 2009. Male patient, 68 years of age, weighting 215.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pleural effusion. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DIGOXIN, ANZEMET, IMODIUM, FUROSEMIDE, AMIODARONE, POTASSIUM, AMBIEN, COUMADIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5217471-3
Erlotinib side effect was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on Jan 03, 2007. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchiectasis, bronchoscopy abnormal, haemoptysis, lung consolidation, necrosis, pleural effusion, pneumonia
, pneumothorax, pulmonary cavitation. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with METFORMIN, GLIMEPIRIDE, MONTELUKAST, TAMSULOSIN, TRIAMCINOLONE, SENNOSIDE, CLARINASE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5230795-9
Erlotinib side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Jan 26, 2007. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchiectasis, diabetes mellitus inadequate control, disease progression, necrosis, pleural effusion, pneumonia
, pneumothorax, subcutaneous emphysema, tuberculosis . Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with METFORMIN, GLIMEPIRIDE, MONTELUKAST, TAMSULOSIN, TRIAMCINOLONE, SENNOSIDE, CLARINASE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5245532-1
Erlotinib side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Feb 02, 2007. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchiectasis, bronchoscopy abnormal, disease progression, haemoptysis, lung consolidation, necrosis, pleural effusion, pneumonia
, pneumothorax. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with METFORMIN, GLIMEPIRIDE, MONTELUKAST, TAMSULOSIN, TRIAMCINOLONE, SENNOSIDE, CLARINASE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #6060244-2
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Jan 14, 2009. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchopneumonia, cardiac failure congestive, malignant neoplasm progression, mucosal inflammation, non-small cell lung cancer, pleural effusion, pulmonary embolism
, rash . Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with ASPIRIN, AMLODIPINE, LACTULOSE, DOMPERIDONE, DIGOXIN, DILTIAZEM, FUROSEMIDE, DEXAMETHASONE. Patient was hospitalized. Patient died on 10/17/2008.Erlotinib Side Effects Report #4851118-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 01, 2005. Female patient, 67 years of age, weighting 173.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bacterial infection
, dilatation atrial, dysphagia, lymphangitis, malignant neoplasm progression, non-small cell lung cancer stage iv, pleural effusion, pulmonary hypertension , sputum culture positive. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AVASTIN, PREDNISONE, COMBIVENT, NORVASC. Patient was hospitalized and became disabled. Patient died on 11/18/2005.Erlotinib Side Effects Report #6058146-0
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Jan 13, 2009. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, fluid intake reduced, hypoxia, lethargy, malignant neoplasm progression, mobility decreased, pleural effusion, pneumonia
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with NYSTATIN, CITALOPRAM HYDROBROMIDE, LORAZEPAM, OXYCODONE. Patient was hospitalized. Patient died on 07/23/2008.Erlotinib Side Effects Report #5869425-1
Erlotinib side effect was reported by a Health Professional from SWITZERLAND on Aug 13, 2008. Female patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cough, pleural effusion, pneumonia
, pyrexia, rhinitis. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5900777-X
Erlotinib side effect was reported by a Health Professional from SWITZERLAND on Sept 12, 2008. Female patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pleural effusion, pneumonia
, rhinitis. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5925694-0
Erlotinib side effect was reported by a Physician from SWITZERLAND on Oct 03, 2008. Female patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malaise, pleural effusion, pneumonia
, rhinitis. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6108678-1
Erlotinib side effect was reported by a Physician from ITALY on Feb 20, 2009. Female patient, 61 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest pain
, pleural effusion. Erlotinib dosage: (150 MG), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5341523-0
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2007. Female patient, 56 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, pleural effusion, pneumonia aspiration, pseudomonas infection, sputum culture positive, tracheal stenosis. Erlotinib dosage: 150MG DAILY ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5798556-X
Erlotinib side effect was reported by a Physician from JAPAN on June 13, 2008. Female patient, 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, depressed level of consciousness, hyperkalaemia, hypernatraemia, interstitial lung disease, platelet count decreased, pleural effusion, pneumocystis jiroveci pneumonia, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with RIZE, CLONAZEPAM, METHYCOBAL, LOXONIN, PRIMPERAN, AMITRIPTYLINE, PURSENNID, FENTANYL TRANSDERMAL SYSTEM. Patient died.
Erlotinib Side Effects Report #5800634-3
Erlotinib side effect was reported by a Physician from UNITED STATES on July 02, 2008. Male patient, 54 years of age, weighting 130.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pleural effusion. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6000193-9
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 11, 2008. Male patient, 54 years of age, weighting 130.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: acute myocardial infarction, coronary artery disease
, pleural effusion, refusal of treatment by patient. Erlotinib dosage: 150MG , ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5712025-4
Erlotinib side effect was reported by a Physician from HONG KONG on Apr 03, 2008. Male patient, 53 years of age, weighting 119.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, dyspnoea, lung consolidation, metastases to pleura, pleural effusion, sinus tachycardia. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient died on 03/20/2008.
Erlotinib Side Effects Report #5729636-2
Erlotinib side effect was reported by a Physician from HONG KONG on Apr 16, 2008. Male patient, 53 years of age, weighting 119.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, blood alkaline phosphatase increased, blood urea increased, dyspnoea, lower respiratory tract infection, lung consolidation, metastases to pleura, pleural effusion, sinus tachycardia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, LIDOCAINE, CHLORPHENIRAMINE MALEATE, BROMHEXINE HYDROCHLORIDE, TERBUTALINE SULPHATE, ALPRAZOLAM. Patient was hospitalized. Patient died on 03/20/2008.
Erlotinib Side Effects Report #5740071-3
Erlotinib side effect was reported by a Physician from HONG KONG on Apr 28, 2008. Male patient, 53 years of age, weighting 119.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, blood alkaline phosphatase increased, blood urea increased, lower respiratory tract infection, lung consolidation, pleural effusion, sinus tachycardia, white blood cell count increased. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with BEVACIZUMAB, LIDOCAINE, CHLORPHENIRAMINE MALEATE, BROMHEXINE HYDROCHLORIDE, TERBUTALINE SULPHATE, ALPRAZOLAM. Patient was hospitalized. Patient died on 03/20/2008.
Erlotinib Side Effects Report #5216877-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 04, 2007. Male patient, 47 years of age, weighting 196.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac arrest
, hypotension, myocardial infarction, pericardial effusion, pleural effusion. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TARGRETIN, METHADONE, ATIVAN, MORPHINE, PREDNISONE, DUONEB, NITROGLYCERIN, ALBUTEROL SULPHATE. Patient died.Erlotinib Side Effects Report #5916946-9
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 24, 2008. Male patient, 47 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, dehydration, flatulence, haemoglobin decreased, ileus, pleural effusion, pleural fibrosis, small intestinal obstruction. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DASATINB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #4816217-8
Erlotinib side effect was reported by a Consumer or non-health professional from SINGAPORE on Oct 04, 2005. Male patient, 46 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cough, lethargy, pleural effusion, pleuritic pain, pyrexia. Erlotinib dosage: 150 MG 1 X PER DAY / ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5308406-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 20, 2007. Male patient, weighting 151.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pleural effusion, pneumonia
. Erlotinib dosage: unknown. Patient recovered.Erlotinib Side Effects Report #5532822-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 30, 2007. Male patient, weighting 203.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, cough, dyspnoea, haemoptysis, hypoxia, lung infection, oxygen saturation decreased, pleural effusion, pyrexia. Erlotinib dosage: 150MG ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5549853-4
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 06, 2007. Male patient, weighting 203.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: computerised tomogram abnormal, cough, dyspnoea, haemoptysis, hypoxia, pleural effusion. Erlotinib dosage: 150MG ORALLY QD. During the same period patient was treated with DASATIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5631933-6
Erlotinib side effect was reported by a Health Professional from ITALY on Jan 28, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pleural effusion. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5776171-1
Erlotinib side effect was reported by a Physician from ITALY on May 30, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pleural effusion. Erlotinib dosage: (150 MG, QD) , ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6084303-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 17, 2009. Female patient, weighting 113.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pericardial effusion, pleural effusion. Erlotinib dosage: 150MG, PO DAILY. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6128181-2
Erlotinib side effect was reported by a Pharmacist from ITALY on Mar 06, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pleural effusion, pulmonary embolism
. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #4881914-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 04, 2005. Female patient, 51 years of age, weighting 144.0 lb, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoglobin decreased, liver function test abnormal, neutrophil percentage increased, pleural effusion, prothrombin time prolonged, pulmonary oedema, red blood cell count decreased, respiratory distress, ventricular dysfunction. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with AVASTIN, CISPLATIN, KLONOPIN, REMERON, RITALIN, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #4795269-8
Erlotinib side effect was reported by a Physician from CANADA on Sept 21, 2005. Female patient was diagnosed with neoplasm, neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pericardial effusion, pleural effusion. Erlotinib dosage: unknown. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5736921-7
Erlotinib side effect was reported by a Physician from ARGENTINA on Apr 25, 2008. Male patient, 60 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, pleural effusion. Erlotinib dosage: (150 MG), ORAL. During the same period patient was treated with MAGNESIUM. Patient died.
Erlotinib Side Effects Report #6075600-6
Erlotinib side effect was reported by a Health Professional from FRANCE on Jan 27, 2009. Male patient, 53 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arrhythmia
, cerebrovascular accident, coma, disease progression, electrocardiogram abnormal, pleural effusion, respiratory rate increased. Erlotinib dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6094382-5
Erlotinib side effect was reported by a Health Professional from FRANCE on Feb 09, 2009. Male patient, 53 years of age, was diagnosed with lung neoplasm malignant, non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebrovascular accident, coma, disease progression, malignant neoplasm progression, pleural effusion. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DOXYCYCLINE. Patient was hospitalized. Patient died on 01/21/2009.
Erlotinib Side Effects Report #5844753-4
Erlotinib side effect was reported by a Consumer or non-health professional from GERMANY on July 30, 2008. Male patient was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pleural effusion. Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with NOVALGIN, CONCOR, ASPIRIN, ZOCOR, MOVICOL, RAMIPRIL, PANTOPRAZOLE, MORPHINE. Patient was hospitalized. Patient died on 08/06/2007.
Erlotinib Side Effects Report #5869421-4
Erlotinib side effect was reported by a Health Professional from GERMANY on Aug 15, 2008. Male patient was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pleural effusion. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with NOVALGIN, CONCOR, ASPIRIN, ZOCOR, MOVICOL, RAMIPRIL, PANTOPRAZOLE, MORPHINE. Patient was hospitalized. Patient died on 08/06/2007.
Erlotinib Side Effects Report #5832820-0
Erlotinib side effect was reported by a Physician from JAPAN on July 17, 2008. Male patient, 89 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion, pneumonia
. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with NAUZELIN, MEDICON, SELBEX, OMEPRAZOLE. Patient died.Erlotinib Side Effects Report #6094377-1
Erlotinib side effect was reported by a Health Professional from JAPAN on Feb 10, 2009. Male patient, 68 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiomegaly, infection
, interstitial lung disease, left ventricular dysfunction, malignant neoplasm progression, pericardial effusion, pleural effusion, pneumonia viral, pyrexia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with AMLODIPINE BESYLATE, MICARDIS, HARNAL, BASEN, GLUFAST, NOVOLIN N, GASMOTIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5648134-8
Erlotinib side effect was reported by a Physician from JAPAN on Feb 14, 2008. Female patient, 62 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, constipation
, dysgeusia, gastritis, hepatic function abnormal, lung disorder, pleural effusion. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with MORPHINE, PRIMPERAN, CALCIUM LACTATE, GLYCYRON, ALFAROL, SUCRALFATE, PREDNISOLONE. Patient recovered.Erlotinib Side Effects Report #5735802-2
Erlotinib side effect was reported by a Physician from JAPAN on Apr 09, 2008. Female patient, 62 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, dysgeusia, hepatic function abnormal, lung consolidation, malignant neoplasm progression, pleural effusion. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with MORPHINE, PRIMPERAN, CALCIUM LACTATE, GLYCYRON, ALFAROL, SUCRALFATE, PREDNISOLONE. Patient died.
Erlotinib Side Effects Report #5691936-2
Erlotinib side effect was reported by a Physician from JAPAN on Feb 15, 2008. Female patient, 57 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arterial disorder, dyspnoea, hypoxia, interstitial lung disease, nail disorder, no therapeutic response, palpatory finding abnormal, pleural effusion, pulmonary hypertension
. Erlotinib dosage: (150 MG,QD),ORAL. Patient died on 01/24/2008.Erlotinib Side Effects Report #5781093-6
Erlotinib side effect was reported by a Physician from UNITED STATES on June 03, 2008. Male patient, weighting 163.1 lb, was diagnosed with hepatic neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, disorientation, pleural effusion. Erlotinib dosage: 150 MG,QD,DAYS 1-28,ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #4657521-6
Erlotinib side effect was reported by a Health Professional from on Apr 22, 2005. Male patient, 53 years of age, weighting 203.0 lb, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, dehydration, diarrhoea, large intestine perforation, metabolic disorder , oral intake reduced, pleural effusion, tachycardia. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, OXALIPLATIN, LEUCOVORIN, ATIVAN, COMPAZINE, LOMOTIL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #4688248-2
Erlotinib side effect was reported by a Physician from on May 24, 2005. Male patient, 53 years of age, weighting 203.0 lb, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, dehydration, diarrhoea, metabolic disorder , oral intake reduced, pleural effusion, tachycardia. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, OXALIPLATIN, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #4735204-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 21, 2005. Male patient, 53 years of age, weighting 203.0 lb, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, intestinal perforation, metabolic disorder
, oral intake reduced, pleural effusion, tachycardia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, OXALIPLATIN, LEUCOVORIN CALCIUM, ATIVAN, COMPAZINE, LOMOTIL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #4815154-2
Erlotinib side effect was reported by a Health Professional from SINGAPORE on Oct 10, 2005. Male patient, 46 years of age, was diagnosed with bronchial neoplasm, lung neoplasm and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, condition aggravated, lung infiltration, mediastinal disorder, pleural effusion, pleuritic pain, pyrexia, rash
. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5230797-2
Erlotinib side effect was reported by a Physician from GERMANY on Jan 19, 2007. Male patient, 65 years of age, was diagnosed with bronchial carcinoma, lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: concomitant disease aggravated, pleural effusion. Erlotinib dosage: unknown. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #4967272-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 15, 2006. Female patient, 58 years of age, weighting 121.9 lb, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest discomfort, disease progression, dyspnoea, haemoglobin decreased, pericardial effusion, pleural effusion, white blood cell count increased. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with EVEROLIMUS, HYDROCODONE BITARTRATE, TUSSIONEX, PHENYLTOLOXAMINE, LEVAQUIN, IRON, CALTRATE, VITAMIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5363515-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 18, 2007. Female patient, 40 years of age, weighting 220.0 lb, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activities of daily living impaired, atrial fibrillation
, blood pressure decreased, dyspnoea, oedema, pleural effusion, respiratory disorder, sedation. Erlotinib dosage: unknown. Patient died on 06/06/2007.Erlotinib Side Effects Report #6060243-0
Erlotinib side effect was reported by a Physician from JAPAN on Jan 14, 2009. Male patient, 73 years of age, weighting 134.9 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebral infarction, depressed level of consciousness, disseminated intravascular coagulation, hemiplegia, interstitial lung disease, lung disorder, pleural effusion, pseudomonas infection, sputum culture positive. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with AMLODIPINE, CANDESARTAN CILEXETIL, LOXOPROFEN, MUCOSTA, LENDORM, CODEINE PHOSPHATE. Patient was hospitalized. Patient died on 12/25/2008.
Erlotinib Side Effects Report #5705300-0
Erlotinib side effect was reported by a Health Professional from JAPAN on Mar 28, 2008. Female patient, 70 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: amnesia, condition aggravated, delirium, inflammation, lymphadenopathy, pleural effusion, pneumonia bacterial, restlessness. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with GENINAX, LASIX, ALDACTONE, PURSENNID, LOSARTAN POTASSIUM, DOGMATYL, ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE, FERROMIA. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5732789-3
Erlotinib side effect was reported by a Pharmacist from UNITED STATES on May 07, 2008. Female patient, 70 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: hepatic enzyme increased, oedema peripheral, pleural effusion, pulmonary toxicity, respiratory acidosis. Erlotinib dosage: unknown. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5935272-5
Erlotinib side effect was reported by a Physician from JAPAN on Oct 13, 2008. Female patient, 70 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: amnesia, aspiration, delirium, disorientation, inflammation, lymphadenopathy, pleural effusion, pneumonia
. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with GENINAX, LASIX, ALDACTONE, FURSENNID, LOSARTAN POTASSIUM, DOGMATYL, ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE, FERROMIA. Patient was hospitalized. Patient died on 04/05/2008.